This text is a result of machine translation.
Excess PV silicon? Industry: the development of large-size silicon wafers exceeds expectations, and the supply is still tight
Jiangsu Hengrui, Chinese Cancer Drugmaker Emerging from the Shadows
A flagship in the Chinese oncology market, Jiangsu Hengrui Medicine (600276:SH) was accused of corruption in sales. This was soon followed by good news – an approval of a Phase III clinical test. Will a bright future erase the black stain?
May 22, 2020 10:52 PM
Huzhou: there is no time limit for non registered residence residents to continuously pay social security when purchasing houses in central cities
The price of new n-type monocrystalline silicon wafer of Zhonghuan Co., Ltd. is 6% higher than that of p-type silicon wafer with the same thickness
Taier shares: the contract dispute case against Cao Linbin was accepted by the court
Luyang energy conservation: the controlling shareholder plans to suspend the trading of shares in major events
Cambridge Industries Group Plans Optical Module Capacity Expansion Across Four Countries
Cambridge Industries Group(剑桥科技), or CIG, reaffirmed plans to add at least 10 million units of annual high-speed optical module capacity by the end of 2027. The expanded capacity will be allocated across production sites in China, Malaysia, Mexico and the United States.
Updated 1 hour ago
Yunnan Baiyao's Revenue Rises 33%; Net Profit Falls 40% in 1Q 2021
On April 27, Yunnan Baiyao released a report for the first quarter of 2021 showing that the company's total operating revenue for the first quarter was 10.33 billion yuan, up 33.4% year-on-year; its operating profit was 880 million yuan, down 41.8% year-on-year; its net profit attributable to shareholders of the listed company was 760 million yuan.
Apr 30, 2021 02:07 AM
The annual report is superimposed on the first quarterly report, and the highlights of listed companies are frequent
Central Co., Ltd. comprehensively raised the price of p-type monocrystalline silicon wafer
Yunnan Baiyao: An Oriental Mystery in the Limelight (2/2)
Tagged as ‘China’s Time-honored Brand,’ Traditional Chinese Medicine (TCM) company Yunnan Baiyao (000538:SZ) has come to an unprecedented crossroads after fulfilling the challenge of pushing TCM to the foreground.
May 19, 2020 12:30 PM
Yunnan Baiyao: An Oriental Mystery in the Limelight (1/2)
Tagged as ‘China’s Time-honored Brand,’ Traditional Chinese Medicine (TCM) company Yunnan Baiyao (000538:SZ) has come to an unprecedented crossroads after fulfilling the challenge of pushing TCM to the foreground.
May 19, 2020 12:00 PM
The Commerce Department said the shortage of chips would continue for at least six months
Revenue Up 283%, Over 60% From Overseas: MiniMax's Global Expansion
Nov 05, 2026 08:41 PM
How BYD Is Turning China's EV Advantages into Global Growth
Nov 05, 2026 08:35 PM
Capital Has No Passport - In an Age of Economic Sovereignty, how to position “China” in European Capital Markets?
Oct 21, 2026 04:46 PM
Which Way Is the Wind Blowing? How to Balance Geopolitics and Heavy Capex Investment
Oct 08, 2026 05:15 PM